Claritas Rx

Claritas Rx — Longitudinal specialty/rare-disease patient treatment-journey panel: consented and de-identified pharmacy, provider, hub and distribution data linked into unified patient journeys — benefit verification and access outcomes, prescription initiation and abandonment events, refill/continuation and time-on-therapy series, omnichannel outreach and intervention logs, and cross-brand performance benchmarks.. Established mid-size specialist (~140 employees, ~$15M revenue, South San Francisco) operating a nationally aggregated specialty/PHO/hub data layer — low record counts relative to …

Claritas Rx offers (Alternative, Fundamental) — Est. multi-million longitudinal patient journeys across specialty, rare and cell & gene therapies (inferred from ~140 employees and ~$15M revenue supporting a national hub/pharmacy aggregation footprint).

Prescription-abandonment prediction and churn model training, adherence intervention uplift modeling and causal-inference experiments, rare-disease cohort identification and patient-finding, market-access and prior-authorization outcome modeling, next-best-action / channel-selection policy learning for patient services, reinforcement-learning reward signals from intervention-outcome pairs, and real-world-evidence endpoints for market approvals.

The data is with 15 years of history.

Coverage spans US; Pharmaceuticals; alternative, fundamental; equities.

The supplier's own access route is a contact form. Request a sample through Brickroad to start.